Cargando…

Non-linear relationship of gamma-glutamyl transpeptidase to lymphocyte count ratio with the recurrence of hepatocellular carcinoma with staging I–II: a retrospective cohort study

BACKGROUND: High recurrence rate was a major factor for the poor postoperative prognosis of hepatocellular carcinoma (HCC) patients. The present study was intended to evaluate the association of gamma-glutamyl transpeptidase to lymphocyte count ratio (GLR) and the recurrence of HCC with staging I–II...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zeping, Liang, Lili, Duan, Wen, Zhou, Chengmao, Yang, Jian-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8991940/
https://www.ncbi.nlm.nih.gov/pubmed/35395799
http://dx.doi.org/10.1186/s13027-022-00428-0
_version_ 1784683677273292800
author Li, Zeping
Liang, Lili
Duan, Wen
Zhou, Chengmao
Yang, Jian-Jun
author_facet Li, Zeping
Liang, Lili
Duan, Wen
Zhou, Chengmao
Yang, Jian-Jun
author_sort Li, Zeping
collection PubMed
description BACKGROUND: High recurrence rate was a major factor for the poor postoperative prognosis of hepatocellular carcinoma (HCC) patients. The present study was intended to evaluate the association of gamma-glutamyl transpeptidase to lymphocyte count ratio (GLR) and the recurrence of HCC with staging I–II in Chinese. METHODS: The retrospective cohort data was derived from the First Affiliated Hospital of Zhengzhou University from January 2014 to December 2018 on 496 patients who underwent radical resection of HCC with staging I–II. Multivariable Cox regression models were used to determine hazard ratios (HR) and 95% confidence interval (CI) for the recurrence of HCC with staging I–II of each GLR tertile category. The restricted cubic spline model was used to find out the threshold effect. RESULTS: With the low tertile of GLR as the reference, multivariable-adjusted HR and 95% CI of the middle and high tertile categories were 1.748 (1.170–2.612) and 2.078 (1.339–3.227). In addition, there was a positive correlation (HR 1.002; 95% CI 1.001–1.004) and a non-liner relationship was found, whose point was 27.5. When the GLR was less than 27.5, the risk of recurrence increased, obviously with the increase in GLR levels (HR 1.041; 95% CI 1.014–1.068). CONCLUSIONS: The GLR was independently associated with the recurrence of HCC patients with staging I–II. Furthermore, the relationship was positive and no-linear.
format Online
Article
Text
id pubmed-8991940
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-89919402022-04-09 Non-linear relationship of gamma-glutamyl transpeptidase to lymphocyte count ratio with the recurrence of hepatocellular carcinoma with staging I–II: a retrospective cohort study Li, Zeping Liang, Lili Duan, Wen Zhou, Chengmao Yang, Jian-Jun Infect Agent Cancer Research Article BACKGROUND: High recurrence rate was a major factor for the poor postoperative prognosis of hepatocellular carcinoma (HCC) patients. The present study was intended to evaluate the association of gamma-glutamyl transpeptidase to lymphocyte count ratio (GLR) and the recurrence of HCC with staging I–II in Chinese. METHODS: The retrospective cohort data was derived from the First Affiliated Hospital of Zhengzhou University from January 2014 to December 2018 on 496 patients who underwent radical resection of HCC with staging I–II. Multivariable Cox regression models were used to determine hazard ratios (HR) and 95% confidence interval (CI) for the recurrence of HCC with staging I–II of each GLR tertile category. The restricted cubic spline model was used to find out the threshold effect. RESULTS: With the low tertile of GLR as the reference, multivariable-adjusted HR and 95% CI of the middle and high tertile categories were 1.748 (1.170–2.612) and 2.078 (1.339–3.227). In addition, there was a positive correlation (HR 1.002; 95% CI 1.001–1.004) and a non-liner relationship was found, whose point was 27.5. When the GLR was less than 27.5, the risk of recurrence increased, obviously with the increase in GLR levels (HR 1.041; 95% CI 1.014–1.068). CONCLUSIONS: The GLR was independently associated with the recurrence of HCC patients with staging I–II. Furthermore, the relationship was positive and no-linear. BioMed Central 2022-04-08 /pmc/articles/PMC8991940/ /pubmed/35395799 http://dx.doi.org/10.1186/s13027-022-00428-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Li, Zeping
Liang, Lili
Duan, Wen
Zhou, Chengmao
Yang, Jian-Jun
Non-linear relationship of gamma-glutamyl transpeptidase to lymphocyte count ratio with the recurrence of hepatocellular carcinoma with staging I–II: a retrospective cohort study
title Non-linear relationship of gamma-glutamyl transpeptidase to lymphocyte count ratio with the recurrence of hepatocellular carcinoma with staging I–II: a retrospective cohort study
title_full Non-linear relationship of gamma-glutamyl transpeptidase to lymphocyte count ratio with the recurrence of hepatocellular carcinoma with staging I–II: a retrospective cohort study
title_fullStr Non-linear relationship of gamma-glutamyl transpeptidase to lymphocyte count ratio with the recurrence of hepatocellular carcinoma with staging I–II: a retrospective cohort study
title_full_unstemmed Non-linear relationship of gamma-glutamyl transpeptidase to lymphocyte count ratio with the recurrence of hepatocellular carcinoma with staging I–II: a retrospective cohort study
title_short Non-linear relationship of gamma-glutamyl transpeptidase to lymphocyte count ratio with the recurrence of hepatocellular carcinoma with staging I–II: a retrospective cohort study
title_sort non-linear relationship of gamma-glutamyl transpeptidase to lymphocyte count ratio with the recurrence of hepatocellular carcinoma with staging i–ii: a retrospective cohort study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8991940/
https://www.ncbi.nlm.nih.gov/pubmed/35395799
http://dx.doi.org/10.1186/s13027-022-00428-0
work_keys_str_mv AT lizeping nonlinearrelationshipofgammaglutamyltranspeptidasetolymphocytecountratiowiththerecurrenceofhepatocellularcarcinomawithstagingiiiaretrospectivecohortstudy
AT lianglili nonlinearrelationshipofgammaglutamyltranspeptidasetolymphocytecountratiowiththerecurrenceofhepatocellularcarcinomawithstagingiiiaretrospectivecohortstudy
AT duanwen nonlinearrelationshipofgammaglutamyltranspeptidasetolymphocytecountratiowiththerecurrenceofhepatocellularcarcinomawithstagingiiiaretrospectivecohortstudy
AT zhouchengmao nonlinearrelationshipofgammaglutamyltranspeptidasetolymphocytecountratiowiththerecurrenceofhepatocellularcarcinomawithstagingiiiaretrospectivecohortstudy
AT yangjianjun nonlinearrelationshipofgammaglutamyltranspeptidasetolymphocytecountratiowiththerecurrenceofhepatocellularcarcinomawithstagingiiiaretrospectivecohortstudy